Health Disparities from Economic Burden of Diabetes in Middle-income Countries: Evidence from México

PLoS ONE

Volumn 8, Issue 7, 2013, Pages

  Arredondo, Armando ^a   Reyes, Gabriela ^a  

^a INSTITUTO NACIONAL DE SALUD PÚBLICA   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ATTITUDE TO HEALTH; BUDGET; CASE MANAGEMENT; COST BENEFIT ANALYSIS; COST OF ILLNESS; DIABETES MELLITUS; HEALTH CARE COST; HEALTH CARE QUALITY; HEALTH CARE UTILIZATION; HEALTH DISPARITY; HUMAN; INCOME; LONGITUDINAL STUDY; MEXICO; MONEY; MORTALITY; PRIVATE HEALTH INSURANCE; PUBLIC HEALTH PROBLEM; SOCIAL PROBLEM;

COST OF ILLNESS; DEVELOPING COUNTRIES; DIABETES MELLITUS; HEALTH CARE COSTS; HEALTHCARE DISPARITIES; HUMANS; INCOME; INSURANCE, HEALTH; MEXICO;

EID: 84880074214     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0068443     Document Type: Article

References (30)

1. Arredondo A, Barceló A, (2007) The Economic Burden of Out-of-Pocket Medical Expenditures for Patients Seeking Diabetes Care in Mexico. Diabetologia 50: 435-36.
2. American Diabetes Association, (2008) Economic Costs of Diabetes in the US. Diabetes Care 31: 596-615.
3. Frenk J, Zurita B, Franco F, Arredondo A, Quisser M, et al. (2012) Demanda y oferta de servicios médicos: Obstáculos a la mejoría del sistema de salud en México. FUNSALUD Ed, México D.F., México. ISBN 968-6186-29-8: pp. 23-46.
4. Caspersen C, Thomas D, Boseman L, Beckles G, Albrigth A, (2012) Aging, diabetes, and the public health system in the United States. Am J Public Health 102 (8): 1482-1497.
5. Secretaría de Salud (2012) Información básica sobre recursos y servicios del Sistema Nacional de Salud. Informe Técnico.: 68-76.
6. Panamerican Health Organization (2012) Health Analysis and Information Systems, Regional Mortality Database: 16.21.
7. Caro J, Ward A, O'Brien J, (2002) Lifetime Costs of Complications Resulting From Type 2 Diabetes in the U.S. Diabetes Care. 25: 476-481.
8. Brown JB, Pedula KL, Bakst AW, (1999) The Progressive Cost of Complications in Type 2 Diabetes Mellitus. Arch Intern Med. 159: 1873-1880.
9. International Diabetes Federation (2010) Direct cost to the health care sector. Diabetes Health Economics. International Diabetes Federation. Brussels, Belgium: 13-15.
10. Dawson KG, Gomes D, Gerstein H, Blanchard JF, Kahler KH, (2002) The economic cost of diabetes in Canada, Diabetes Care. 25: 1303-7.
11. Barcelo A, Daroca MC, Ribera R, Duarte E, Zapata A, et al. (2001) Diabetes in Bolivia. Pan American Juo of Public Health 10: 318-23.
12. International Diabetes Federation (2010) Direct cost to the health care sector. Diabetes Health Economics. International Diabetes Federation. Brussels, Belgium: 29-35.
13. Instituto Nacional de Salud Pública (2012) Encuesta Nacional de Salud y Nutrición-2012. Daños y servicios de la salud. Cuernavaca, Mex. INSP-SSA-: 74-81.
14. Arredondo A, Zuñiga A, (2004) Economic Burden of Diabetes in Middle-Income Countries: The Mexican Case. Diabetes Care 29, No. 1: 104-109.
15. SSA IMSS, ISSSTE (2012) Boletín de Información Estadística. Casos de morbilidad hospitalaria por demanda específica, 1993-2010. SSA Ed. México, D.F.: 12-17.
16. SSA IMSS, ISSSTE (2008) Programa Nacional de Salud 2001-2006. 2007-2012. La democratización de la salud en México: Hacia un sistema universal de salud. SSA Ed. México, D.F.: 15-49.
17. SSA (2004) Información básica sobre recursos y servicios del Sistema Nacional de Salud. Salud Pública de México 42, No. 1 68-76: 2003.
18. Dawson KG, Gomes D, Gerstein H, Blanchard JF, Kahler KH, (2002) The economic cost of diabetes in Canada, Diabetes Care. 25: 1303-7.
19. American Diabetes Association, (1998) Economic Consequences of Diabetes Mellitus in the U.S. Diabetes Care, 21. (2): 296-309.
20. Snowdon A, Schnarr K, Hussein A, Alessi CH (2012) Measuring What Matters: The Cost vs. Values of Health Care. International Centre for Health Innovation, Richard Ivey School of Business, Western University. Ontario CA: 12-20.
21. Wild S, Roglic G, Green A, Sicree R, King H, (2004) Global Prevalence of Diabetes. Estimates for the year 2000 and projections for 2030. Diabetes Care 27(5): 1047-1053.
22. Zhang P, Zhang X, Brown J, Vistisen D, Sicree R, et al. (2010) Global healthcare expenditure on diabetes for 2010 and 2030. Diabetes Research 87: 293-301.
23. SSA (2010) Sistema Nacional de Salud, Catálogo de compra consolidada de insumos al sector salud. (2010). Medicamentos, material desechable, soluciones y equipo. SSA, México DF 2010: 38-59.
24. Barceló A, Aedo C, Rajpathak S, Robles S, (2003) The cost of diabetes in Latin America and the Caribbean. Bulletin of the World Health Organization 81(1): 19-27.
25. Instituto Nacional de Salud Pública (2012) Métodos de estimación de demanda esperada de enfermedades crónico-degenerativas. Informe Técnico de Memoria Metodológica. Cuernavaca, México.: 63-78.
26. SSA IMSS, ISSSTE (2011) Boletín de Información Estadística. Casos de mortalidad general y especifica por tipo de institución, 2001-2010. SSA Ed. México, D.F.: 7-23.
27. Instituto Nacional de Estadística (2012) Producto Interno Bruto Nacional, Pércapita, por Estado y por región de México. Inf-INEGI 2011. México DF.
28. Murray A, (2005) Statistical Modelling and Statistical Inference: Measurement error in the explanatory variables. Box-Jenkins technique, in Statistical Modelling in GLIM. Oxford Science Publications, Ox. Uni. Press, New York, U.S.A.; Third Ed. Chap.2: 112-132.
29. Banco de México (2012) Indice Nacional de Precios por Servicios Médicos en México. Cuadernos Mensuales, Base 1990 = 100. La Actividad Económica en México. 1992-2012. Gerencia de Investigación Económica. Banco de México Ed. México DF, México: 46-68.
30. Arredondo A, Icaza E, (2009) Financial requirements for diabetes in Latin America: evidence and implications to the health system and to patients in Mexico. Diabetologia, 2009, Vol 52: 1693-1695.